Clinical Trials on Myoepithelkarzinom
Total 0 results
Nothing found
Sponsors and Collaborators
- Sudimplant SAS - Groupe TBR
- United States Department of Defense (DOD)
- Paulo Sérgio Gomes Nogueira Borges
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- Julian Taylor Green
- Lilly PharmaceuticalCompany
- Plethora Solutions Ltd
- Rivierduinen, Centre for Personality disorders Jelgersma
- Iyad Naeem Muhammad, PhD
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- Foshan Sanshui District People's Hospital
- S-Biotek Holding ApS
- University of Applied Sciences Jena
- Arsha Vidya Tirtha
- Cardiovascular Center Dedinje, Belgrade, Serbia
- Korea Otsuka International Asia Arab
- Oblikue Consulting
- Eurotrials Brasil Consultores Cientificos Ltda
- Gunkang Pharmaceuticals, Inc
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- View Full List
Medical Conditions
- Chemotherapy-Induced Neutropenia
- Advance Directive Completion
- Malaria,Falciparum
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Puberty, Delayed
- Blepharospasm of Both Eyelids
- Hypothermia Following Anesthesia, Sequela
- Testicular Teratoma
- Vibration; Exposure
- Serum Albumin Low
- Gray Platelet Syndrome
- Brain Tumor, Primary
- Huntington Chorea
- Immunologically-induced Lung Disease
- Thyroid and Parathyroid Surgery
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Visual Attention Span Deficit
- Deformity Flexion
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- Anemia Acute
- View Full List
Drug Interventions
- Pemetrexed
- Rovalpituzumab tesirine
- S-Adenosyl-Methionine
- F520
- Sorafenib
- ABY-035 i.v.
- Mineralocorticoid receptor antagonist
- Ebselen
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- Cyanoacrylate
- Oxycodone
- Celecoxib
- Standard medical therapy
- Bimatoprost 0.03% eye drops
- Pegfilgrastim
- Acalabrutinib in combination with VR
- Vosaroxin
- MMV390048 120mg
- Cytisine
- Furmonertinib 160 mg
- View Full List
CROs by country
- Contract Research Organizations in Angola
- Contract Research Organizations in Australia
- Contract Research Organizations in Bangladesh
- Contract Research Organizations in Brazil
- Contract Research Organizations in Egypt
- Contract Research Organizations in Gabon
- Contract Research Organizations in Guatemala
- Contract Research Organizations in Malawi
- Contract Research Organizations in Mauritania
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in Serbia
- Contract Research Organizations in Uzbekistan
- Contract Research Organizations in Zimbabwe
- CRO list by country